Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine

Esophageal cancers are highly aggressive tumors with poor prognosis despite some recent advances in surgical and radiochemotherapy treatment options. This study addressed the feasibility of drugs targeting epigenetic modifiers in esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinom...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Epigenetics
Main Authors: Ahrens, Theresa D, Timme, Sylvia, Hoeppner, Jens, Ostendorp, Jenny, Hembach, Sina, Follo, Marie, Hopt, Ulrich T, Werner, Martin, Busch, Hauke, Boerries, Melanie, Lassmann, Silke
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2015
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4623041/
https://ncbi.nlm.nih.gov/pubmed/25923331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15592294.2015.1039216
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados